With the CDC and NIH now muzzled, scrubbing data and studies, an important source to follow is the Center for Infectious Disease Research and Policy at the U of MN.
Reposted from
CIDRAP
Tamiflu cuts risk of death in older adults, study suggests
Oseltamivir recipients had a 18% lower risk of 30-day mortality.
www.cidrap.umn.edu/i...
Photo: andrew wales/Flickr cc
Oseltamivir recipients had a 18% lower risk of 30-day mortality.
www.cidrap.umn.edu/i...
Photo: andrew wales/Flickr cc
Comments